eBEAUTYSOURCE

Sale!

TRANSINO II SKIN WHITENING SUPPLEMENT FOR MELASMA 120 TABLETS

Original price was: $100.00.Current price is: $75.00.

Transino II Tablets

Brand: Transino, a leading Japanese skincare brand, known for its award-winning efficacy in treating melasma.

Product: Transino II Tablets

Key Ingredient: Tranexamic Acid – effectively lightens hyperpigmentation caused by aging and sun exposure.

Dosage: Take 2 tablets twice daily.

Supply: 120 tablets per bottle, providing a 1-month supply.

Benefits: Reduces age spots, evens skin tone, and brightens complexion. Widely acclaimed for its effectiveness.

 

Description

Active Ingredient:

Tranexamic Acid: A potent agent known for its targeted action against melasma and persistent hyperpigmentation. Tranexamic acid works by inhibiting melanin production, effectively lightening dark spots and evening out skin tone.

Efficacy:

Melasma Improvement: Clinical studies have demonstrated that Transino II significantly improves melasma after consistent use over 8 weeks. This makes it an effective option for reducing melasma and other stubborn hyperpigmented areas.

Spot Lightening: Proven to be effective in diminishing age spots and pigmentation caused by sun exposure and aging. Users report noticeable improvements in skin clarity and tone after a 2-month course.

Visible Benefits:

Reduction of Age Spots: Effective in lightening solar-induced and age-related dark spots.

Enhanced Evenness: Helps to even out facial tone and reduce pigmentation irregularities.

Brightening Effect: Contributes to a brighter, more radiant complexion.

How to Use: Adults (from 15 years old) : 2 tablets x 2 times per day after the meal. Should stop after continuous taking for 2 months and take again after the next 2 months or when your skin has melanin or melasma problem.

Made in Japan

Brand

DAIICHI SANKYO COMPANY

Transino

Reviews

There are no reviews yet.

Be the first to review “TRANSINO II SKIN WHITENING SUPPLEMENT FOR MELASMA 120 TABLETS”

Your email address will not be published. Required fields are marked *

en_USEnglish